Cell Line Development

Efficient. Scalable. Reliable.

The CHO platform delivers high-yield, stable clones with unmatched speed and productivity. Built on a CHO-GS platform, engineered for fast growth,strong secretion, and optimal glycosylation, it accelerates cell line development while ensuring monoclonality and long-term stability.

Glo-Fusion™ - Upstream Process Development

Powered By Next-Generation Perfusion (NGP) Technology

Glo-Fusion™ integrates advanced NGP strategies to enable intensified, high-cell-density, high-productivity upstream processes that enhance speed, scalability, and robustness. Its unmatched productivity supports reliable, cost-effective manufacturing to meet global demand.

Key Advantages:

• Ultra-High Cell Densities: 80-100 million cells/mL in perfusion
• Ultra High productivities: 60-75g/L in Glo-Fusion™-NGP
• Scalable Efficiency: Seamless transition from 2L -> 200L -> 500L bioreactors
• Reduced Footprint & Cost: Smaller reactor volumes with lower CapEx and COGs
• Accelerated Timelines: Faster development and tech transfer for clinical and commercial supply